|
Hypertrophy
Citations 501-510 of 683 total displayed.
|
Past content
(since Mar 1999):
|
- Scientific Contributions
Aldosterone Increases NHE-1 Expression and Induces NHE-1-Dependent Hypertrophy in Neonatal Rat Ventricular Myocytes
- Morris Karmazyn, Que Liu, Xiaohong Tracey Gan, Brenda J. Brix, and Larry Fliegel
Hypertension 2003;42:1171-1176; published online before print as doi:10.1161/01.HYP.0000102863.23854.0B
[Abstract]
[Full text]
- Scientific Contributions
Aldosterone Increases NHE-1 Expression and Induces NHE-1-Dependent Hypertrophy in Neonatal Rat Ventricular Myocytes
- Morris Karmazyn, Que Liu, Xiaohong Tracey Gan, Brenda J. Brix, and Larry Fliegel
Hypertension published November 10, 2003, doi:10.1161/01.HYP.0000102863.23854.0B
[Abstract]
- AHA Scientific Statement
Kidney Disease as a Risk Factor for Development of Cardiovascular Disease: A Statement From the American Heart Association Councils on Kidney in Cardiovascular Disease, High Blood Pressure Research, Clinical Cardiology, and Epidemiology and Prevention
- Mark J. Sarnak, Andrew S. Levey, Anton C. Schoolwerth, Josef Coresh, Bruce Culleton, L. Lee Hamm, Peter A. McCullough, Bertram L. Kasiske, Ellie Kelepouris, Michael J. Klag, Patrick Parfrey, Marc Pfeffer, Leopoldo Raij, David J. Spinosa, and Peter W. Wilson
Hypertension 2003;42:1050-1065, doi:10.1161/01.HYP.0000102971.85504.7c
[Full text]
- Brief Reviews
Reactive Oxygen Species in the Vasculature. Molecular and Cellular Mechanisms
- Yoshihiro Taniyama and Kathy K. Griendling
Hypertension published October 27, 2003, doi:10.1161/01.HYP.0000100443.09293.4F
[Abstract]
- Scientific Contributions
Relation Between Left Ventricular Midwall Function and Coronary Vasodilator Capacity in Arterial Hypertension
- Michaela Kozàkovà, Ele Ferrannini, and Carlo Palombo
Hypertension 2003;42:528-533; published online before print as doi:10.1161/01.HYP.0000090120.22445.B0
[Abstract]
[Full text]
- State of the Art Lectures
Peroxisome Proliferator-Activated Receptors: Vascular and Cardiac Effects in Hypertension
- Ernesto L. Schiffrin, Farhad Amiri, Karim Benkirane, Marc Iglarz, and Quy N. Diep
Hypertension 2003;42:664-668; published online before print as doi:10.1161/01.HYP.0000084370.74777.B6
[Abstract]
[Full text]
- Scientific Contributions, Part 2
Peroxisome Proliferator-Activated Receptor- and Receptor- Activators Prevent Cardiac Fibrosis in Mineralocorticoid-Dependent Hypertension
- Marc Iglarz, Rhian M. Touyz, Emilie C. Viel, Pierre Paradis, Farhad Amiri, Quy N. Diep, and Ernesto L. Schiffrin
Hypertension 2003;42:737-743; published online before print as doi:10.1161/01.HYP.0000083511.91817.B1
[Abstract]
[Full text]
- Scientific Contributions, Part 2
PPAR Inhibition of Cyclooxygenase-2, PGE2 Synthase, and Inducible Nitric Oxide Synthase in Cardiac Myocytes
- Mariela Mendez and Margot C. LaPointe
Hypertension 2003;42:844-850; published online before print as doi:10.1161/01.HYP.0000085332.69777.D1
[Abstract]
[Full text]
- Scientific Contributions
Relation Between Left Ventricular Midwall Function and Coronary Vasodilator Capacity in Arterial Hypertension
- Michaela Kozàkovà, Ele Ferrannini, and Carlo Palombo
Hypertension published September 2, 2003, doi:10.1161/01.HYP.0000090120.22445.B0
[Abstract]
- Scientific Contributions
African Americans With LVH Demonstrate Depressed Sensitivity of the Coronary Microcirculation to Stimulated Relaxation
- Jan Laws Houghton, David S. Strogatz, Mikhail T. Torosoff, Vivienne E. Smith, Steven A. Fein, Patricia A. Kuhner, Edward F. Philbin, and Albert A. Carr
Hypertension 2003;42:269-276; published online before print as doi:10.1161/01.HYP.0000087840.43329.01
[Abstract]
[Full text]
|
|